Trial Profile
Immunogenicity and Safety of Gardasil and Twinrix Vaccines Co-administered or Administered a Month Apart, According to the 0, 6 Months Schedule and the Effect of a Third Dose of Gardasil or Cervarix Administered 42 Months Later
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Mar 2020
Price :
$35
*
At a glance
- Drugs Human papillomavirus vaccine recombinant bivalent Japan Vaccine/MedImmune (Primary) ; Hepatitis A-hepatitis B vaccine; Human papillomavirus vaccine recombinant quadrivalent Merck
- Indications Cervical cancer; Human papillomavirus infections
- Focus Pharmacodynamics
- 04 Mar 2020 Status changed from recruiting to completed.
- 20 Oct 2011 New trial record